These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16859513)

  • 1. The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.
    Shapira M; Kakiashvili E; Rosenberg T; Hershko DD
    Breast Cancer Res; 2006; 8(4):R46. PubMed ID: 16859513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of the ubiquitin ligase subunit Cks1 in human breast cancer.
    Slotky M; Shapira M; Ben-Izhak O; Linn S; Futerman B; Tsalic M; Hershko DD
    Breast Cancer Res; 2005; 7(5):R737-44. PubMed ID: 16168119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.
    Liu X; Wang H; Ma J; Xu J; Sheng C; Yang S; Sun L; Ni Q
    Med Oncol; 2013 Dec; 30(4):735. PubMed ID: 24277465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin resistance is linked to defective regulation of Skp2.
    Totary-Jain H; Sanoudou D; Dautriche CN; Schneller H; Zambrana L; Marks AR
    Cancer Res; 2012 Apr; 72(7):1836-43. PubMed ID: 22311674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.
    Fukuchi M; Masuda N; Nakajima M; Fukai Y; Miyazaki T; Kato H; Kuwano H
    Anticancer Res; 2004; 24(2B):777-83. PubMed ID: 15161026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
    Huang HC; Way TD; Lin CL; Lin JK
    Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
    Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
    Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition.
    Liu W; Wu G; Li W; Lobur D; Wan Y
    Mol Cell Biol; 2007 Apr; 27(8):2967-79. PubMed ID: 17283060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
    Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells.
    Bar-On O; Shapira M; Hershko DD
    Anticancer Drugs; 2007 Nov; 18(10):1113-21. PubMed ID: 17893511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
    Chen JY; Wang MC; Hung WC
    J Cell Physiol; 2011 Feb; 226(2):407-13. PubMed ID: 20717963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
    Lin R; Wang TT; Miller WH; White JH
    Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
    Fujita T; Liu W; Doihara H; Date H; Wan Y
    Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.